Stay updated on SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Sign up to get notified when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.

Latest updates to the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page
- Check6 days agoChange DetectedPage revision tag updated to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site Revision: v3.4.2 and removed older Revision: v3.4.1 along with a government-funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding and operating status was added, with links to cc.nih.gov and opm.gov for updates. The site version was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle and minor wording edits to labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') and updated the revision tag from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 is shown on the page, replacing the previous v3.3.3. There are no apparent changes to core trial details like objectives, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section updated to include Florida, Iowa, Oregon, and Texas. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.5%

Stay in the know with updates to SAR422459 in Stargardt's Macular Degeneration Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR422459 in Stargardt's Macular Degeneration Clinical Trial page.